Opendata, web and dolomites

Epi4MS SIGNED

Targeting the epigenome: towards a better understanding of disease pathogenesis and novel therapeutic strategies in Multiple Sclerosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Epi4MS project word cloud

Explore the words cloud of the Epi4MS project. It provides you a very rough idea of what is the project "Epi4MS" about.

sclerosis    edge    corrected    capture    epigenome    stage    organ    individuals    triggered    modulating    vitro    rational    modifiable    adults    insights    immune    models    code    formulated    biobank    nature    therapeutic    mediate    progressive    ms    combined    discovery    utilize    facets    functional    animal    aggressive    precision    sustained    inflammatory    disability    editing    laboratory    stable    cutting    unpredictable    unbiased    diseases    provides    correcting    regulators    medicine    gain    throughput    mechanisms    treating    starting    therapies    synergistic    predisposed    pathogenesis    disease    young    reversal    innovative    vivo    cells    inducing    dissect    pathogenic    self    added    epigenetic    extensive    marks    unknown    incurable    expression    aberrant    mediated    chronic    complement    reversible    genetically    alternative    gene    genetic    spearheading    dna    shift    regulate    molecular    multiple    prioritize    paradigm    methylation    powerful    screens    environmental    causal    point    exact    preventing   

Project "Epi4MS" data sheet

The following table provides information about the project.

Coordinator
KAROLINSKA INSTITUTET 

Organization address
address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177
website: www.ki.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 1˙998˙798 €
 EC max contribution 1˙998˙798 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2024-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET SE (STOCKHOLM) coordinator 1˙998˙798.00

Map

 Project objective

Multiple Sclerosis (MS) is a leading cause of unpredictable and incurable progressive disability in young adults. Although the exact cause remains unknown, this immune-mediated disease is likely triggered by environmental factors in genetically predisposed individuals. I propose that epigenetic mechanisms, which regulate gene expression without affecting the genetic code, mediate the processes that cause MS and that aberrant epigenetic states can be corrected, spearheading the development of alternative therapies. We will exploit the stable and reversible nature of epigenetic marks, in particular DNA methylation, to gain insights into the novel modifiable disease mechanisms by studying the target organ in a way that has not been possible before. This highly ambitious project comprises three synergistic facets formulated in specific aims to: (i) identify epigenetic states that characterize the pathogenesis of MS, (ii) prioritize functional epigenetic states using high-throughput epigenome-screens, and (iii) develop novel approaches for precision medicine based on correcting causal epigenetic states. Our unique MS biobank combined with cutting-edge methodologies to capture pathogenic cells and measure their functional states provides a rational starting point to identify MS targets. I will complement this approach with studies of the functional impact of MS targets using innovative in vitro screens, with the added value of unbiased discovery of robust regulators of specific MS pathways. Finally, my laboratory has extensive experience with animal models of MS and I will utilize these powerful systems to dissect molecular mechanisms of MS targets and test the therapeutic potential of targeted epigenome editing in vivo. Our findings will set the stage for a paradigm-shift in studying and treating chronic inflammatory diseases based on preventing and modulating aggressive immune responses by inducing self-sustained reversal of aberrant epigenetic states.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPI4MS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPI4MS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

Aware (2019)

Aiding Antibiotic Development with Deep Analysis of Resistance Evolution

Read More  

Resonances (2019)

Resonances and Zeta Functions in Smooth Ergodic Theory and Geometry

Read More  

CARBYNE (2020)

New carbon reactivity rules for molecular editing

Read More